Rebecca Richards
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rebecca Richards has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Amy L. Ahern
Institute of Metabolic Science Epidemiology, School of Clinical Medicine, University of Cambridge, Cambridge, UK
8 shared publications - Michael Whitman
Second Nature, 483 Green Lanes, London, GB
8 shared publications - Fiona Wood
Division of Population Medicine, Cardiff University School of Medicine, Cardiff, Wales, United Kingdom
7 shared publications - Kate Brain
Division of Population Medicine, Cardiff University, Cardiff, UK
7 shared publications - Gina M. Wren
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
6 shared publications - Paul Kinnersley
Centre for Medical Education, Cardiff University, Cardiff, United Kingdom
6 shared publications
Latest Publications
- Open Access
- 30 June 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9 (1) , e72577
A Remotely Delivered GLP-1RA–Supported Specialist Weight Management Program in Adults Living With Obesity: Retrospective Service Evaluation
Background: Limited access to specialist weight management services restricts the implementation of novel pharmacotherapies for obesity such as glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the UK National Health Service (NHS). Second Nature, a commercial digital health company, offers a remotely delivered program combining a GLP-1RA medication (semaglutide) with digital behavioral support, potentially providing a scalable solution. However, evidence for long-term effectiveness in this real-world context is limited. Objective: This study aimed to evaluate the 12-month effectiveness, feasibility, acceptability, and potential cost-effectiveness of the remotely delivered, semaglutide-supported weight management program by Second Nature. Methods: This retrospective service evaluation analyzed data from participants who initiated the program between September and December 2023. The primary outcome was weight change at 12 months among participants with available data (completers). Secondary outcomes included retention, program engagement (measured by views of the Home screen in the app), behavioral changes, side effects, participant experience (qualitative analysis), and a comparative cost analysis against an NHS specialist weight management service. An “active subscription” was defined as maintaining a paid subscription for the full 12-month period. Descriptive statistics and paired 2-tailed t tests evaluated outcomes. Results: Data from 341 participants were included at baseline (282/341, 82.7% women; mean age 49, SD 11.1 years; mean baseline BMI 37.9, SD 6.9 kg/m2). At 12 months, 39.6% (135/206) maintained an active subscription, while 60.4% (206/341) became inactive. Weight data at 12 months were available for 179 participants (52.5% of the baseline cohort; 100% of active and 19.4% of inactive participants). Among completers who maintained an active subscription, the mean weight loss was 20.0 kg (SD 8.7 kg; P<.001), representing 19.1% of starting weight. Overall, 77.7% (139/179) of completers achieved ≥10% weight loss and 61.5% (110/179) achieved ≥15%. Program engagement declined over time. Side effects also decreased, with 69.6% (81/116) of respondents reporting none by month 12. Most participants completing the 12-month survey reported positive (41/120, 34.2%) or neutral (68/120, 56.7%) experiences. Conclusions: This evaluation suggests that remotely delivered GLP-1RA–supported weight management can achieve significant weight loss in participants remaining engaged for 12 months. However, the high rate of withdrawal limits generalizability. The program appears feasible, acceptable, and potentially cost-effective for completers. Further research, ideally in public health care settings using intent-to-treat analyses, is needed to confirm clinical outcomes, assess sustained results, and understand factors influencing retention.
- 30 June 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9 (1) , e72577
Open AccessA Remotely Delivered GLP-1RA–Supported Specialist Weight Management Program in Adults Living With Obesity: Retrospective Service Evaluation
Background: Limited access to specialist weight management services restricts the implementation of novel pharmacotherapies for obesity such as glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the UK National Health Service (NHS). Second Nature, a commercial digital health company, offers a remotely delivered program combining a GLP-1RA medication (semaglutide) with digital behavioral support, potentially providing a scalable solution. However, evidence for long-term effectiveness in this real-world context is limited. Objective: This study aimed to evaluate the 12-month effectiveness, feasibility, acceptability, and potential cost-effectiveness of the remotely delivered, semaglutide-supported weight management program by Second Nature. Methods: This retrospective service evaluation analyzed data from participants who initiated the program between September and December 2023. The primary outcome was weight change at 12 months among participants with available data (completers). Secondary outcomes included retention, program engagement (measured by views of the Home screen in the app), behavioral changes, side effects, participant experience (qualitative analysis), and a comparative cost analysis against an NHS specialist weight management service. An “active subscription” was defined as maintaining a paid subscription for the full 12-month period. Descriptive statistics and paired 2-tailed t tests evaluated outcomes. Results: Data from 341 participants were included at baseline (282/341, 82.7% women; mean age 49, SD 11.1 years; mean baseline BMI 37.9, SD 6.9 kg/m2). At 12 months, 39.6% (135/206) maintained an active subscription, while 60.4% (206/341) became inactive. Weight data at 12 months were available for 179 participants (52.5% of the baseline cohort; 100% of active and 19.4% of inactive participants). Among completers who maintained an active subscription, the mean weight loss was 20.0 kg (SD 8.7 kg; P<.001), representing 19.1% of starting weight. Overall, 77.7% (139/179) of completers achieved ≥10% weight loss and 61.5% (110/179) achieved ≥15%. Program engagement declined over time. Side effects also decreased, with 69.6% (81/116) of respondents reporting none by month 12. Most participants completing the 12-month survey reported positive (41/120, 34.2%) or neutral (68/120, 56.7%) experiences. Conclusions: This evaluation suggests that remotely delivered GLP-1RA–supported weight management can achieve significant weight loss in participants remaining engaged for 12 months. However, the high rate of withdrawal limits generalizability. The program appears feasible, acceptable, and potentially cost-effective for completers. Further research, ideally in public health care settings using intent-to-treat analyses, is needed to confirm clinical outcomes, assess sustained results, and understand factors influencing retention.
- Open Access
- 22 March 2025
- Published by Wiley in Obesity Science & Practice
- Vol. 11 (2) , e70048
An Acceptance‐Based Guided Self‐Help Program for Weight Loss Maintenance in Adults Who Have Previously Completed a Behavioral Weight Loss Program: The SWiM Feasibility Study
Background: Most weight lost during weight‐loss programmes is eventually regained. Interventions based on Acceptance and Commitment Therapy (ACT) demonstrate good evidence for long‐term weight loss, but are often costly and difficult to scale up. Guided self‐help programmes delivered using technology and non‐specialist coaches could increase scalability, but it is unclear whether delivering ACT‐based interventions in this way is feasible and acceptable. Methods: In this feasibility study, 61 people who recently completed a behavioral weight management intervention (BWMI) for weight management were randomly allocated to SWiM (“Supporting Weight Management”: 4‐month digital guided self‐help ACT‐based intervention for weight loss maintenance) or a standard care group (leaflet about maintaining weight loss) using a 2:1 allocation ratio. At baseline and 6 months, participants completed measures of weight, mental health, eating behavior, and other psychosocial variables. Participants completed an intervention evaluation questionnaire. At 3 and 6 months, qualitative interviews were conducted with participants from both trial arms and SWiM coaches. The analysis integrated statistics and thematic analysis, informed by the Medical Research Council (MRC) framework for process evaluations. Since this was a feasibility study, analyses focused on process outcomes instead of interpreting statistical significance. Results: Eighty‐eight percent (36/41) of participants allocated to SWiM completed at least the first session and 22 (54%) completed all sessions. At 6 months, mean weight change was −2.2 (+/−6.4 SD) kg in SWiM participants and +2.2 (+/−6.6) kg in standard care participants. Descriptively, eating behavior and mental health scores improved in SWiM participants but not in standard care participants. In interviews, SWiM participants noted that they reinforced their existing knowledge while acquiring new skills and strategies, which were felt to contribute to positive behavioral changes. Conclusion: The SWiM intervention is practical and well‐received, and shows promise in supporting weight loss maintenance, though evaluation in a larger trial is needed to assess effectiveness. Trial Registration: ISRCTN12685964
- 22 March 2025
- Published by Wiley in Obesity Science & Practice
- Vol. 11 (2) , e70048
Open AccessAn Acceptance‐Based Guided Self‐Help Program for Weight Loss Maintenance in Adults Who Have Previously Completed a Behavioral Weight Loss Program: The SWiM Feasibility Study
Background: Most weight lost during weight‐loss programmes is eventually regained. Interventions based on Acceptance and Commitment Therapy (ACT) demonstrate good evidence for long‐term weight loss, but are often costly and difficult to scale up. Guided self‐help programmes delivered using technology and non‐specialist coaches could increase scalability, but it is unclear whether delivering ACT‐based interventions in this way is feasible and acceptable. Methods: In this feasibility study, 61 people who recently completed a behavioral weight management intervention (BWMI) for weight management were randomly allocated to SWiM (“Supporting Weight Management”: 4‐month digital guided self‐help ACT‐based intervention for weight loss maintenance) or a standard care group (leaflet about maintaining weight loss) using a 2:1 allocation ratio. At baseline and 6 months, participants completed measures of weight, mental health, eating behavior, and other psychosocial variables. Participants completed an intervention evaluation questionnaire. At 3 and 6 months, qualitative interviews were conducted with participants from both trial arms and SWiM coaches. The analysis integrated statistics and thematic analysis, informed by the Medical Research Council (MRC) framework for process evaluations. Since this was a feasibility study, analyses focused on process outcomes instead of interpreting statistical significance. Results: Eighty‐eight percent (36/41) of participants allocated to SWiM completed at least the first session and 22 (54%) completed all sessions. At 6 months, mean weight change was −2.2 (+/−6.4 SD) kg in SWiM participants and +2.2 (+/−6.6) kg in standard care participants. Descriptively, eating behavior and mental health scores improved in SWiM participants but not in standard care participants. In interviews, SWiM participants noted that they reinforced their existing knowledge while acquiring new skills and strategies, which were felt to contribute to positive behavioral changes. Conclusion: The SWiM intervention is practical and well‐received, and shows promise in supporting weight loss maintenance, though evaluation in a larger trial is needed to assess effectiveness. Trial Registration: ISRCTN12685964
- Open Access
- 14 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A Remotely Delivered GLP-1RA–Supported Specialist Weight Management Program in Adults Living With Obesity: Retrospective Service Evaluation (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Limited access to specialist weight management services restricts the implementation of novel pharmacotherapies for obesity such as glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the UK National Health Service (NHS). Second Nature, a commercial digital health company, offers a remotely delivered program combining a GLP-1RA medication (semaglutide) with digital behavioral support, potentially providing a scalable solution. However, evidence for long-term effectiveness in this real-world context is limited. Objective: This study aimed to evaluate the 12-month effectiveness, feasibility, acceptability, and potential cost-effectiveness of the remotely delivered, semaglutide-supported weight management program by Second Nature. Methods: This retrospective service evaluation analyzed data from participants who initiated the program between September and December 2023. The primary outcome was weight change at 12 months among participants with available data (completers). Secondary outcomes included retention, program engagement (measured by views of the Home screen in the app), behavioral changes, side effects, participant experience (qualitative analysis), and a comparative cost analysis against an NHS specialist weight management service. An “active subscription” was defined as maintaining a paid subscription for the full 12-month period. Descriptive statistics and paired 2-tailed t tests evaluated outcomes. Results: Data from 341 participants were included at baseline (282/341, 82.7% women; mean age 49, SD 11.1 years; mean baseline BMI 37.9, SD 6.9 kg/m2). At 12 months, 39.6% (135/206) maintained an active subscription, while 60.4% (206/341) became inactive. Weight data at 12 months were available for 179 participants (52.5% of the baseline cohort; 100% of active and 19.4% of inactive participants). Among completers who maintained an active subscription, the mean weight loss was 20.0 kg (SD 8.7 kg; P<.001), representing 19.1% of starting weight. Overall, 77.7% (139/179) of completers achieved ≥10% weight loss and 61.5% (110/179) achieved ≥15%. Program engagement declined over time. Side effects also decreased, with 69.6% (81/116) of respondents reporting none by month 12. Most participants completing the 12-month survey reported positive (41/120, 34.2%) or neutral (68/120, 56.7%) experiences. Conclusions: This evaluation suggests that remotely delivered GLP-1RA–supported weight management can achieve significant weight loss in participants remaining engaged for 12 months. However, the high rate of withdrawal limits generalizability. The program appears feasible, acceptable, and potentially cost-effective for completers. Further research, ideally in public health care settings using intent-to-treat analyses, is needed to confirm clinical outcomes, assess sustained results, and understand factors influencing retention.
- 14 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Remotely Delivered GLP-1RA–Supported Specialist Weight Management Program in Adults Living With Obesity: Retrospective Service Evaluation (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Limited access to specialist weight management services restricts the implementation of novel pharmacotherapies for obesity such as glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the UK National Health Service (NHS). Second Nature, a commercial digital health company, offers a remotely delivered program combining a GLP-1RA medication (semaglutide) with digital behavioral support, potentially providing a scalable solution. However, evidence for long-term effectiveness in this real-world context is limited. Objective: This study aimed to evaluate the 12-month effectiveness, feasibility, acceptability, and potential cost-effectiveness of the remotely delivered, semaglutide-supported weight management program by Second Nature. Methods: This retrospective service evaluation analyzed data from participants who initiated the program between September and December 2023. The primary outcome was weight change at 12 months among participants with available data (completers). Secondary outcomes included retention, program engagement (measured by views of the Home screen in the app), behavioral changes, side effects, participant experience (qualitative analysis), and a comparative cost analysis against an NHS specialist weight management service. An “active subscription” was defined as maintaining a paid subscription for the full 12-month period. Descriptive statistics and paired 2-tailed t tests evaluated outcomes. Results: Data from 341 participants were included at baseline (282/341, 82.7% women; mean age 49, SD 11.1 years; mean baseline BMI 37.9, SD 6.9 kg/m2). At 12 months, 39.6% (135/206) maintained an active subscription, while 60.4% (206/341) became inactive. Weight data at 12 months were available for 179 participants (52.5% of the baseline cohort; 100% of active and 19.4% of inactive participants). Among completers who maintained an active subscription, the mean weight loss was 20.0 kg (SD 8.7 kg; P<.001), representing 19.1% of starting weight. Overall, 77.7% (139/179) of completers achieved ≥10% weight loss and 61.5% (110/179) achieved ≥15%. Program engagement declined over time. Side effects also decreased, with 69.6% (81/116) of respondents reporting none by month 12. Most participants completing the 12-month survey reported positive (41/120, 34.2%) or neutral (68/120, 56.7%) experiences. Conclusions: This evaluation suggests that remotely delivered GLP-1RA–supported weight management can achieve significant weight loss in participants remaining engaged for 12 months. However, the high rate of withdrawal limits generalizability. The program appears feasible, acceptable, and potentially cost-effective for completers. Further research, ideally in public health care settings using intent-to-treat analyses, is needed to confirm clinical outcomes, assess sustained results, and understand factors influencing retention.
- Open Access
- 3 February 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e71914
A remotely-delivered weight management service to support existing obesity services in the UK National Health Service: Preliminary findings from an early-stage service evaluation (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Specialist weight management services (SWMS) in the UK National Health Service (NHS) are faced with long waiting lists and limited resources. Remotely-delivered SWMSs have the potential to support existing NHS services to increase access to treatment for patients living with obesity, however evidence of remotely-delivered services working to support NHS SWMSs in practice remains limited. Objective: This service evaluation explored the potential effectiveness, feasibility and acceptability of Second Nature’s remotely-delivered SWMS for adults living with obesity referred from existing NHS SWMSs. Preliminary findings from the first phase (‘Preparing for weight loss’) of a three-phase remotely-delivered SWMS are presented. Methods: Participants were referred to Second Nature by NHS SWMS leads. Eligible participants were assessed by a multidisciplinary team and allocated to one of three 16-week interventions: 1) a psychologically informed app-based program, 2) a Dialectical behavioral Therapy (DBT)-based skills training group program and 3) one-to-one psychological support. Primary outcomes were weight change (kg) and percentage weight change following completion of the intervention. Secondary outcomes included psychological distress, emotional eating, health-related quality of life, physical activity, emotion regulation, intervention feasibility and acceptability. Results: At 16-weeks, there were significant differences in weight (p=.012), with an average weight change of -2.2kg (SD 5.16) (-1.6% body weight). Participants in the app-based program lost the most weight (-2.8kg), and participants in the one-to-one psychological support program lost the least weight (-1.3kg). Psychological distress reduced to below the clinical threshold (mean score 0.95, SD 0.62) (p<.001). Emotional eating behaviors and difficulties in emotion regulation also decreased (p=.027 and p<.001). Health-related quality of life saw improvements in self-care, usual activities and anxiety/depression (p=.044; p=.014; p=.029), while participants’ challenges with mobility and pain/discomfort remained unaffected (p>.05). Subjective ratings of health status improved by 17.4% (p=.003). There were no significant changes in physical activity levels (p=.264), with most participants remaining ‘Inactive’ or ‘Moderately inactive’. Engagement with intervention sessions was high (93.7%) and attrition rate was 27.4%. Participants rated their satisfaction with the program at 9/10, while also providing insightful suggestions for future service improvement, such as improved app-functionality and more accessible physical activity support. Conclusions: This preliminary service evaluation suggests that a remotely delivered SWMS has the potential to be effective, feasible and acceptable for NHS-referred patients in the UK. A full evaluation of all three phases of this service with a larger sample size is required to support these early findings.
- 3 February 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e71914
Open AccessA remotely-delivered weight management service to support existing obesity services in the UK National Health Service: Preliminary findings from an early-stage service evaluation (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Specialist weight management services (SWMS) in the UK National Health Service (NHS) are faced with long waiting lists and limited resources. Remotely-delivered SWMSs have the potential to support existing NHS services to increase access to treatment for patients living with obesity, however evidence of remotely-delivered services working to support NHS SWMSs in practice remains limited. Objective: This service evaluation explored the potential effectiveness, feasibility and acceptability of Second Nature’s remotely-delivered SWMS for adults living with obesity referred from existing NHS SWMSs. Preliminary findings from the first phase (‘Preparing for weight loss’) of a three-phase remotely-delivered SWMS are presented. Methods: Participants were referred to Second Nature by NHS SWMS leads. Eligible participants were assessed by a multidisciplinary team and allocated to one of three 16-week interventions: 1) a psychologically informed app-based program, 2) a Dialectical behavioral Therapy (DBT)-based skills training group program and 3) one-to-one psychological support. Primary outcomes were weight change (kg) and percentage weight change following completion of the intervention. Secondary outcomes included psychological distress, emotional eating, health-related quality of life, physical activity, emotion regulation, intervention feasibility and acceptability. Results: At 16-weeks, there were significant differences in weight (p=.012), with an average weight change of -2.2kg (SD 5.16) (-1.6% body weight). Participants in the app-based program lost the most weight (-2.8kg), and participants in the one-to-one psychological support program lost the least weight (-1.3kg). Psychological distress reduced to below the clinical threshold (mean score 0.95, SD 0.62) (p<.001). Emotional eating behaviors and difficulties in emotion regulation also decreased (p=.027 and p<.001). Health-related quality of life saw improvements in self-care, usual activities and anxiety/depression (p=.044; p=.014; p=.029), while participants’ challenges with mobility and pain/discomfort remained unaffected (p>.05). Subjective ratings of health status improved by 17.4% (p=.003). There were no significant changes in physical activity levels (p=.264), with most participants remaining ‘Inactive’ or ‘Moderately inactive’. Engagement with intervention sessions was high (93.7%) and attrition rate was 27.4%. Participants rated their satisfaction with the program at 9/10, while also providing insightful suggestions for future service improvement, such as improved app-functionality and more accessible physical activity support. Conclusions: This preliminary service evaluation suggests that a remotely delivered SWMS has the potential to be effective, feasible and acceptable for NHS-referred patients in the UK. A full evaluation of all three phases of this service with a larger sample size is required to support these early findings.
- Open Access
- 3 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
The potential of a remotely-delivered weight management service to support existing specialist weight management services in the UK National Health Service: Preliminary findings from a pilot service evaluation (Preprint)
BACKGROUND Specialist weight management services (SWMS) in the UK National Health Service (NHS) are faced with long waiting lists and limited resources. Remotely-delivered SWMSs have the potential to support existing NHS services to increase access to treatment for patients living with obesity, however evidence of remotely-delivered services working to support NHS SWMSs in practice remains limited. OBJECTIVE This service evaluation explored the potential effectiveness, feasibility and acceptability of Second Nature’s remotely-delivered SWMS for adults living with obesity referred from existing NHS SWMSs. Preliminary findings from the first phase (‘Preparing for weight loss’) of a three-phase remotely-delivered SWMS are presented. METHODS Participants were referred to Second Nature by NHS SWMS leads. Eligible participants were assessed by a multidisciplinary team and allocated to one of three 16-week interventions: 1) a psychologically informed app-based program, 2) a Dialectical behavioral Therapy (DBT)-based skills training group program and 3) one-to-one psychological support. Primary outcomes were weight change (kg) and percentage weight change following completion of the intervention. Secondary outcomes included psychological distress, emotional eating, health-related quality of life, physical activity, emotion regulation, intervention feasibility and acceptability. RESULTS At 16-weeks, there were significant differences in weight (p=.012), with an average weight change of -2.2kg (SD 5.16) (-1.6% body weight). Participants in the app-based program lost the most weight (-2.8kg), and participants in the one-to-one psychological support program lost the least weight (-1.3kg). Psychological distress reduced to below the clinical threshold (mean score 0.95, SD 0.62) (p<.001). Emotional eating behaviors and difficulties in emotion regulation also decreased (p=.027 and p<.001). Health-related quality of life saw improvements in self-care, usual activities and anxiety/depression (p=.044; p=.014; p=.029), while participants’ challenges with mobility and pain/discomfort remained unaffected (p>.05). Subjective ratings of health status improved by 17.4% (p=.003). There were no significant changes in physical activity levels (p=.264), with most participants remaining ‘Inactive’ or ‘Moderately inactive’. Engagement with intervention sessions was high (93.7%) and attrition rate was 27.4%. Participants rated their satisfaction with the program at 9/10, while also providing insightful suggestions for future service improvement, such as improved app-functionality and more accessible physical activity support. CONCLUSIONS This preliminary service evaluation suggests that a remotely delivered SWMS has the potential to be effective, feasible and acceptable for NHS-referred patients in the UK. A full evaluation of all three phases of this service with a larger sample size is required to support these early findings.
- 3 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe potential of a remotely-delivered weight management service to support existing specialist weight management services in the UK National Health Service: Preliminary findings from a pilot service evaluation (Preprint)
BACKGROUND Specialist weight management services (SWMS) in the UK National Health Service (NHS) are faced with long waiting lists and limited resources. Remotely-delivered SWMSs have the potential to support existing NHS services to increase access to treatment for patients living with obesity, however evidence of remotely-delivered services working to support NHS SWMSs in practice remains limited. OBJECTIVE This service evaluation explored the potential effectiveness, feasibility and acceptability of Second Nature’s remotely-delivered SWMS for adults living with obesity referred from existing NHS SWMSs. Preliminary findings from the first phase (‘Preparing for weight loss’) of a three-phase remotely-delivered SWMS are presented. METHODS Participants were referred to Second Nature by NHS SWMS leads. Eligible participants were assessed by a multidisciplinary team and allocated to one of three 16-week interventions: 1) a psychologically informed app-based program, 2) a Dialectical behavioral Therapy (DBT)-based skills training group program and 3) one-to-one psychological support. Primary outcomes were weight change (kg) and percentage weight change following completion of the intervention. Secondary outcomes included psychological distress, emotional eating, health-related quality of life, physical activity, emotion regulation, intervention feasibility and acceptability. RESULTS At 16-weeks, there were significant differences in weight (p=.012), with an average weight change of -2.2kg (SD 5.16) (-1.6% body weight). Participants in the app-based program lost the most weight (-2.8kg), and participants in the one-to-one psychological support program lost the least weight (-1.3kg). Psychological distress reduced to below the clinical threshold (mean score 0.95, SD 0.62) (p<.001). Emotional eating behaviors and difficulties in emotion regulation also decreased (p=.027 and p<.001). Health-related quality of life saw improvements in self-care, usual activities and anxiety/depression (p=.044; p=.014; p=.029), while participants’ challenges with mobility and pain/discomfort remained unaffected (p>.05). Subjective ratings of health status improved by 17.4% (p=.003). There were no significant changes in physical activity levels (p=.264), with most participants remaining ‘Inactive’ or ‘Moderately inactive’. Engagement with intervention sessions was high (93.7%) and attrition rate was 27.4%. Participants rated their satisfaction with the program at 9/10, while also providing insightful suggestions for future service improvement, such as improved app-functionality and more accessible physical activity support. CONCLUSIONS This preliminary service evaluation suggests that a remotely delivered SWMS has the potential to be effective, feasible and acceptable for NHS-referred patients in the UK. A full evaluation of all three phases of this service with a larger sample size is required to support these early findings.
- Open Access
- 24 January 2024
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 9, e52987
The Potential of a Digital Weight Management Program to Support Specialist Weight Management Services in the UK National Health Service: Retrospective Analysis
Background: Digital weight management interventions (DWMIs) have the potential to support existing specialist weight management services (SWMS) in the National Health Service (NHS) to increase access to treatment for people living with obesity and type 2 diabetes. At present, there is limited real-world evidence and long-term outcomes on the potential effectiveness of DWMIs to support such services. Objective: This study aimed to examine real-world data to evaluate the impact of Second Nature’s 12-month DWMI for patients living with obesity with or without type 2 diabetes, referred from NHS primary care services, on sustained weight loss over a 2-year period. Methods: Retrospective data were extracted in August 2023 for participants who participated in the program between January 1, 2017, and January 8, 2021. Eligible participants were adults with a BMI ≥35 kg/m2, with or without type 2 diabetes. The primary outcomes were weight change in kilograms and percentage weight change at 2 years. Secondary outcomes were weight loss at 1 year, program engagement, and the proportion of participants who achieved >5% and >10% weight loss. Differences in weight loss between baseline and the 1- and 2-year follow-up points were compared using paired 2-tailed t tests. Linear regression models were used to examine whether participants’ ethnicity, indices of multiple deprivation, presence of type 2 diabetes, or program engagement were associated with weight loss at 1 year or 2 years. Results: A total of 1130 participants with a mean baseline BMI of 46.3 (SD 31.6) kg/m2 were included in the analysis. Of these participants, 65% (740/1130) were female (mean age 49.9, SD 12.0 years), 18.1% (205/339) were from Black, Asian, mixed, or other ethnicities, and 78.2% (884/1130) had type 2 diabetes. A total of 281 (24.9%) participants recorded weight readings at 2 years from baseline, with a mean weight loss of 13.8 kg (SD 14.2 kg; P<.001) or 11.8% (SD 10.9%; P<.001). A total of 204 (18.1%) participants achieved ≥5% weight loss, and 130 (11.5%) participants reached ≥10% weight loss. Weight loss did not significantly differ by ethnicity, indices of multiple deprivation, presence of type 2 diabetes, or engagement in the program. Conclusions: The findings suggested that Second Nature’s DWMI has the potential to support people living with obesity and type 2 diabetes remotely to achieve clinically significant and sustained weight loss at 2 years from baseline. Further research is needed to compare the intervention to standard care and assess integration with multidisciplinary clinical teams and pharmacotherapy in order to support this study’s findings.
- 24 January 2024
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 9, e52987
Open AccessThe Potential of a Digital Weight Management Program to Support Specialist Weight Management Services in the UK National Health Service: Retrospective Analysis
Background: Digital weight management interventions (DWMIs) have the potential to support existing specialist weight management services (SWMS) in the National Health Service (NHS) to increase access to treatment for people living with obesity and type 2 diabetes. At present, there is limited real-world evidence and long-term outcomes on the potential effectiveness of DWMIs to support such services. Objective: This study aimed to examine real-world data to evaluate the impact of Second Nature’s 12-month DWMI for patients living with obesity with or without type 2 diabetes, referred from NHS primary care services, on sustained weight loss over a 2-year period. Methods: Retrospective data were extracted in August 2023 for participants who participated in the program between January 1, 2017, and January 8, 2021. Eligible participants were adults with a BMI ≥35 kg/m2, with or without type 2 diabetes. The primary outcomes were weight change in kilograms and percentage weight change at 2 years. Secondary outcomes were weight loss at 1 year, program engagement, and the proportion of participants who achieved >5% and >10% weight loss. Differences in weight loss between baseline and the 1- and 2-year follow-up points were compared using paired 2-tailed t tests. Linear regression models were used to examine whether participants’ ethnicity, indices of multiple deprivation, presence of type 2 diabetes, or program engagement were associated with weight loss at 1 year or 2 years. Results: A total of 1130 participants with a mean baseline BMI of 46.3 (SD 31.6) kg/m2 were included in the analysis. Of these participants, 65% (740/1130) were female (mean age 49.9, SD 12.0 years), 18.1% (205/339) were from Black, Asian, mixed, or other ethnicities, and 78.2% (884/1130) had type 2 diabetes. A total of 281 (24.9%) participants recorded weight readings at 2 years from baseline, with a mean weight loss of 13.8 kg (SD 14.2 kg; P<.001) or 11.8% (SD 10.9%; P<.001). A total of 204 (18.1%) participants achieved ≥5% weight loss, and 130 (11.5%) participants reached ≥10% weight loss. Weight loss did not significantly differ by ethnicity, indices of multiple deprivation, presence of type 2 diabetes, or engagement in the program. Conclusions: The findings suggested that Second Nature’s DWMI has the potential to support people living with obesity and type 2 diabetes remotely to achieve clinically significant and sustained weight loss at 2 years from baseline. Further research is needed to compare the intervention to standard care and assess integration with multidisciplinary clinical teams and pharmacotherapy in order to support this study’s findings.
- Open Access
- 28 December 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e53619
A Remotely Delivered, Semaglutide-Supported Specialist Weight Management Program: Preliminary Findings From a Retrospective Service Evaluation
Background: Digital weight management interventions have the potential to increase access to novel pharmacotherapy for people living with obesity. At present, there is limited real-world evidence on the effectiveness, feasibility, and acceptability of this type of intervention. Objective: This retrospective service evaluation examines real-world data to evaluate the preliminary impact of Second Nature’s 24-month, remotely delivered, semaglutide-supported weight management intervention for adults living with obesity at 12 weeks. Methods: Retrospective data were extracted in October 2023 for participants who started the intervention between June 8, 2023, and July 22, 2023. The primary outcomes were weight change (kg) and percentage of weight change at 12 weeks. The secondary outcomes were the proportion of participants who achieved ≥5% and ≥10% weight loss and the feasibility and acceptability of this type of intervention. Descriptive statistics were used to evaluate the baseline characteristics, retention, engagement, prevalence of side effects, and weight change. A paired 2-tailed t test was used to determine the significance of weight change. Content analysis was used to analyze the free-text questionnaire responses. Results: A total of 113 participants with a mean baseline BMI of 38.4 kg/m2 (SD 7.3) were included in the analysis (n=102, 90.4% women, mean age 46.6, SD 11.1 years). Over 12 weeks, 23% (n=26) of participants withdrew from the intervention. A total of 70.8% (n=80) of participants provided weight data at 12 weeks. The average weight loss observed over this 12-week period was 6.5 (SD 4.4) kg (P<.001) or 6.4% (SD 4.2%) of their starting weight (P<.001). Of the 80 participants who recorded weight readings, 62.5% (n=50) achieved ≥5% weight loss, and 11.3% (n=9) achieved ≥10% weight loss. Engagement with the app-based program declined from a mean of 131 (SD 142.6) home screen views in week 0 to 35 (SD 57.1) in week 11. Common side effects reported over 12 weeks included feeling more tired than usual, constipation, and feeling sick. However, a significant proportion of participants reported no side effects. Most participants (n=106, 93.8%) did not experience any difficulties in medication administration. Qualitative data showed that most participants had a positive or neutral experience of the intervention, with some reporting perceived benefits as early as 4 weeks. Most participants did not feel that improvements in the intervention were needed; however, some participants faced issues with medication shipping or logistics. Conclusions: This retrospective preliminary service evaluation suggests that a remotely delivered semaglutide-supported weight management intervention has the potential to be effective, feasible, and acceptable for self-paying consumer adults with obesity in the United Kingdom. Areas for further improvement were highlighted, including user engagement in an app-based program. A full-service evaluation at the end of the 24-month intervention with a larger sample size is required to support these early findings.
- 28 December 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e53619
Open AccessA Remotely Delivered, Semaglutide-Supported Specialist Weight Management Program: Preliminary Findings From a Retrospective Service Evaluation
Background: Digital weight management interventions have the potential to increase access to novel pharmacotherapy for people living with obesity. At present, there is limited real-world evidence on the effectiveness, feasibility, and acceptability of this type of intervention. Objective: This retrospective service evaluation examines real-world data to evaluate the preliminary impact of Second Nature’s 24-month, remotely delivered, semaglutide-supported weight management intervention for adults living with obesity at 12 weeks. Methods: Retrospective data were extracted in October 2023 for participants who started the intervention between June 8, 2023, and July 22, 2023. The primary outcomes were weight change (kg) and percentage of weight change at 12 weeks. The secondary outcomes were the proportion of participants who achieved ≥5% and ≥10% weight loss and the feasibility and acceptability of this type of intervention. Descriptive statistics were used to evaluate the baseline characteristics, retention, engagement, prevalence of side effects, and weight change. A paired 2-tailed t test was used to determine the significance of weight change. Content analysis was used to analyze the free-text questionnaire responses. Results: A total of 113 participants with a mean baseline BMI of 38.4 kg/m2 (SD 7.3) were included in the analysis (n=102, 90.4% women, mean age 46.6, SD 11.1 years). Over 12 weeks, 23% (n=26) of participants withdrew from the intervention. A total of 70.8% (n=80) of participants provided weight data at 12 weeks. The average weight loss observed over this 12-week period was 6.5 (SD 4.4) kg (P<.001) or 6.4% (SD 4.2%) of their starting weight (P<.001). Of the 80 participants who recorded weight readings, 62.5% (n=50) achieved ≥5% weight loss, and 11.3% (n=9) achieved ≥10% weight loss. Engagement with the app-based program declined from a mean of 131 (SD 142.6) home screen views in week 0 to 35 (SD 57.1) in week 11. Common side effects reported over 12 weeks included feeling more tired than usual, constipation, and feeling sick. However, a significant proportion of participants reported no side effects. Most participants (n=106, 93.8%) did not experience any difficulties in medication administration. Qualitative data showed that most participants had a positive or neutral experience of the intervention, with some reporting perceived benefits as early as 4 weeks. Most participants did not feel that improvements in the intervention were needed; however, some participants faced issues with medication shipping or logistics. Conclusions: This retrospective preliminary service evaluation suggests that a remotely delivered semaglutide-supported weight management intervention has the potential to be effective, feasible, and acceptable for self-paying consumer adults with obesity in the United Kingdom. Areas for further improvement were highlighted, including user engagement in an app-based program. A full-service evaluation at the end of the 24-month intervention with a larger sample size is required to support these early findings.
- Open Access
- 16 October 2023
- Published by JMIR Publications Inc. in JMIR Preprints
A Remotely Delivered, Semaglutide-Supported Specialist Weight Management Program: Preliminary Findings From a Retrospective Service Evaluation (Preprint)
BACKGROUND Digital weight management interventions have the potential to increase access to novel pharmacotherapy for people living with obesity. At present, there is limited real-world evidence on the effectiveness, feasibility, and acceptability of this type of intervention. OBJECTIVE This retrospective service evaluation examines real-world data to evaluate the preliminary impact of Second Nature’s 24-month, remotely delivered, semaglutide-supported weight management intervention for adults living with obesity at 12 weeks. METHODS Retrospective data were extracted in October 2023 for participants who started the intervention between June 8, 2023, and July 22, 2023. The primary outcomes were weight change (kg) and percentage of weight change at 12 weeks. The secondary outcomes were the proportion of participants who achieved ≥5% and ≥10% weight loss and the feasibility and acceptability of this type of intervention. Descriptive statistics were used to evaluate the baseline characteristics, retention, engagement, prevalence of side effects, and weight change. A paired 2-tailed t test was used to determine the significance of weight change. Content analysis was used to analyze the free-text questionnaire responses. RESULTS A total of 113 participants with a mean baseline BMI of 38.4 kg/m2 (SD 7.3) were included in the analysis (n=102, 90.4% women, mean age 46.6, SD 11.1 years). Over 12 weeks, 23% (n=26) of participants withdrew from the intervention. A total of 70.8% (n=80) of participants provided weight data at 12 weeks. The average weight loss observed over this 12-week period was 6.5 (SD 4.4) kg (P<.001) or 6.4% (SD 4.2%) of their starting weight (P<.001). Of the 80 participants who recorded weight readings, 62.5% (n=50) achieved ≥5% weight loss, and 11.3% (n=9) achieved ≥10% weight loss. Engagement with the app-based program declined from a mean of 131 (SD 142.6) home screen views in week 0 to 35 (SD 57.1) in week 11. Common side effects reported over 12 weeks included feeling more tired than usual, constipation, and feeling sick. However, a significant proportion of participants reported no side effects. Most participants (n=106, 93.8%) did not experience any difficulties in medication administration. Qualitative data showed that most participants had a positive or neutral experience of the intervention, with some reporting perceived benefits as early as 4 weeks. Most participants did not feel that improvements in the intervention were needed; however, some participants faced issues with medication shipping or logistics. CONCLUSIONS This retrospective preliminary service evaluation suggests that a remotely delivered semaglutide-supported weight management intervention has the potential to be effective, feasible, and acceptable for self-paying consumer adults with obesity in the United Kingdom. Areas for further improvement were highlighted, including user engagement in an app-based program. A full-service evaluation at the end of the 24-month intervention with a larger sample size is required to support these early findings.
- 16 October 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Remotely Delivered, Semaglutide-Supported Specialist Weight Management Program: Preliminary Findings From a Retrospective Service Evaluation (Preprint)
BACKGROUND Digital weight management interventions have the potential to increase access to novel pharmacotherapy for people living with obesity. At present, there is limited real-world evidence on the effectiveness, feasibility, and acceptability of this type of intervention. OBJECTIVE This retrospective service evaluation examines real-world data to evaluate the preliminary impact of Second Nature’s 24-month, remotely delivered, semaglutide-supported weight management intervention for adults living with obesity at 12 weeks. METHODS Retrospective data were extracted in October 2023 for participants who started the intervention between June 8, 2023, and July 22, 2023. The primary outcomes were weight change (kg) and percentage of weight change at 12 weeks. The secondary outcomes were the proportion of participants who achieved ≥5% and ≥10% weight loss and the feasibility and acceptability of this type of intervention. Descriptive statistics were used to evaluate the baseline characteristics, retention, engagement, prevalence of side effects, and weight change. A paired 2-tailed t test was used to determine the significance of weight change. Content analysis was used to analyze the free-text questionnaire responses. RESULTS A total of 113 participants with a mean baseline BMI of 38.4 kg/m2 (SD 7.3) were included in the analysis (n=102, 90.4% women, mean age 46.6, SD 11.1 years). Over 12 weeks, 23% (n=26) of participants withdrew from the intervention. A total of 70.8% (n=80) of participants provided weight data at 12 weeks. The average weight loss observed over this 12-week period was 6.5 (SD 4.4) kg (P<.001) or 6.4% (SD 4.2%) of their starting weight (P<.001). Of the 80 participants who recorded weight readings, 62.5% (n=50) achieved ≥5% weight loss, and 11.3% (n=9) achieved ≥10% weight loss. Engagement with the app-based program declined from a mean of 131 (SD 142.6) home screen views in week 0 to 35 (SD 57.1) in week 11. Common side effects reported over 12 weeks included feeling more tired than usual, constipation, and feeling sick. However, a significant proportion of participants reported no side effects. Most participants (n=106, 93.8%) did not experience any difficulties in medication administration. Qualitative data showed that most participants had a positive or neutral experience of the intervention, with some reporting perceived benefits as early as 4 weeks. Most participants did not feel that improvements in the intervention were needed; however, some participants faced issues with medication shipping or logistics. CONCLUSIONS This retrospective preliminary service evaluation suggests that a remotely delivered semaglutide-supported weight management intervention has the potential to be effective, feasible, and acceptable for self-paying consumer adults with obesity in the United Kingdom. Areas for further improvement were highlighted, including user engagement in an app-based program. A full-service evaluation at the end of the 24-month intervention with a larger sample size is required to support these early findings.
- Open Access
- 22 September 2023
- Published by JMIR Publications Inc. in JMIR Preprints
The Potential of a Digital Weight Management Program to Support Specialist Weight Management Services in the UK National Health Service: Retrospective Analysis (Preprint)
BACKGROUND Digital weight management interventions (DWMIs) have the potential to support existing specialist weight management services (SWMS) in the National Health Service (NHS) to increase access to treatment for people living with obesity and type 2 diabetes. At present, there is limited real-world evidence and long-term outcomes on the potential effectiveness of DWMIs to support such services. OBJECTIVE This study aimed to examine real-world data to evaluate the impact of Second Nature’s 12-month DWMI for patients living with obesity with or without type 2 diabetes, referred from NHS primary care services, on sustained weight loss over a 2-year period. METHODS Retrospective data were extracted in August 2023 for participants who participated in the program between January 1, 2017, and January 8, 2021. Eligible participants were adults with a BMI ≥35 kg/m2, with or without type 2 diabetes. The primary outcomes were weight change in kilograms and percentage weight change at 2 years. Secondary outcomes were weight loss at 1 year, program engagement, and the proportion of participants who achieved >5% and >10% weight loss. Differences in weight loss between baseline and the 1- and 2-year follow-up points were compared using paired 2-tailed t tests. Linear regression models were used to examine whether participants’ ethnicity, indices of multiple deprivation, presence of type 2 diabetes, or program engagement were associated with weight loss at 1 year or 2 years. RESULTS A total of 1130 participants with a mean baseline BMI of 46.3 (SD 31.6) kg/m2 were included in the analysis. Of these participants, 65% (740/1130) were female (mean age 49.9, SD 12.0 years), 18.1% (205/339) were from Black, Asian, mixed, or other ethnicities, and 78.2% (884/1130) had type 2 diabetes. A total of 281 (24.9%) participants recorded weight readings at 2 years from baseline, with a mean weight loss of 13.8 kg (SD 14.2 kg; P<.001) or 11.8% (SD 10.9%; P<.001). A total of 204 (18.1%) participants achieved ≥5% weight loss, and 130 (11.5%) participants reached ≥10% weight loss. Weight loss did not significantly differ by ethnicity, indices of multiple deprivation, presence of type 2 diabetes, or engagement in the program. CONCLUSIONS The findings suggested that Second Nature’s DWMI has the potential to support people living with obesity and type 2 diabetes remotely to achieve clinically significant and sustained weight loss at 2 years from baseline. Further research is needed to compare the intervention to standard care and assess integration with multidisciplinary clinical teams and pharmacotherapy in order to support this study’s findings.
- 22 September 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Potential of a Digital Weight Management Program to Support Specialist Weight Management Services in the UK National Health Service: Retrospective Analysis (Preprint)
BACKGROUND Digital weight management interventions (DWMIs) have the potential to support existing specialist weight management services (SWMS) in the National Health Service (NHS) to increase access to treatment for people living with obesity and type 2 diabetes. At present, there is limited real-world evidence and long-term outcomes on the potential effectiveness of DWMIs to support such services. OBJECTIVE This study aimed to examine real-world data to evaluate the impact of Second Nature’s 12-month DWMI for patients living with obesity with or without type 2 diabetes, referred from NHS primary care services, on sustained weight loss over a 2-year period. METHODS Retrospective data were extracted in August 2023 for participants who participated in the program between January 1, 2017, and January 8, 2021. Eligible participants were adults with a BMI ≥35 kg/m2, with or without type 2 diabetes. The primary outcomes were weight change in kilograms and percentage weight change at 2 years. Secondary outcomes were weight loss at 1 year, program engagement, and the proportion of participants who achieved >5% and >10% weight loss. Differences in weight loss between baseline and the 1- and 2-year follow-up points were compared using paired 2-tailed t tests. Linear regression models were used to examine whether participants’ ethnicity, indices of multiple deprivation, presence of type 2 diabetes, or program engagement were associated with weight loss at 1 year or 2 years. RESULTS A total of 1130 participants with a mean baseline BMI of 46.3 (SD 31.6) kg/m2 were included in the analysis. Of these participants, 65% (740/1130) were female (mean age 49.9, SD 12.0 years), 18.1% (205/339) were from Black, Asian, mixed, or other ethnicities, and 78.2% (884/1130) had type 2 diabetes. A total of 281 (24.9%) participants recorded weight readings at 2 years from baseline, with a mean weight loss of 13.8 kg (SD 14.2 kg; P<.001) or 11.8% (SD 10.9%; P<.001). A total of 204 (18.1%) participants achieved ≥5% weight loss, and 130 (11.5%) participants reached ≥10% weight loss. Weight loss did not significantly differ by ethnicity, indices of multiple deprivation, presence of type 2 diabetes, or engagement in the program. CONCLUSIONS The findings suggested that Second Nature’s DWMI has the potential to support people living with obesity and type 2 diabetes remotely to achieve clinically significant and sustained weight loss at 2 years from baseline. Further research is needed to compare the intervention to standard care and assess integration with multidisciplinary clinical teams and pharmacotherapy in order to support this study’s findings.
- Open Access
- 13 September 2022
- Published by Taylor & Francis in International Journal of Qualitative Studies on Health and Well-being
- Vol. 17 (1) , 2123093
Participants' experiences of mental health during a COVID-19 tailored ACT-based behavioural weight management intervention: a qualitative study
We aimed to explore participants' experiences of mental health during an acceptance and commitment therapy (ACT)-based guided self-help intervention to support weight management in adults with over...
- 13 September 2022
- Published by Taylor & Francis in International Journal of Qualitative Studies on Health and Well-being
- Vol. 17 (1) , 2123093
Open AccessParticipants' experiences of mental health during a COVID-19 tailored ACT-based behavioural weight management intervention: a qualitative study
We aimed to explore participants' experiences of mental health during an acceptance and commitment therapy (ACT)-based guided self-help intervention to support weight management in adults with over...